Carbenoxolone
As of the edition of 20 October 2026, Carbenoxolone is a small molecule: marketed; acts on HSD11B1 and HSD11B2.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Carbosan
- Approvals on record
- 4 in 4 regions
- Holder of the most recent approval
- Rowa Pharmaceuticals Limited
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.